AIT Bioscience, a bioanalytical contract research organisation that is part of Indiana's life sciences hub, has named Jeff Goddard, MBA, as its new chief executive officer and member of the company's board of directors effective 16 October 2019, it was reported yesterday.
Goddard's career ranges from start-ups to Fortune 500 firms. He has held positions of increasing responsibility at companies including EPL Archives, Biostorage Technologies (now Brooks Life Science), Gene Logic and Nalco Chemical Company.
Goddard received his Bachelor of Science degree in Chemical Engineering from the University of Notre Dame and his Master of Business Administration from George Washington University.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer